Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Alternatively spliced mRNA isoforms as prognostic indicators for metastatic cancer

Alternatively spliced mRNA isoforms as prognostic indicators for metastatic cancer

US Patent 9926601 · Granted Mar 27, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Splicing-dependent transcriptional gene silencing or activation2025
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediate2025
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediate2025
Combined markers for metastatic cancer and uses thereof2024
Combined markers for metastatic cancer and uses thereof2024
High resolution intravital imaging and uses thereof2024
TMEM active test and uses thereof in diagnosis, prognosis and treatment of tumor2024
Method for treating neoadjuvant chemotherapy-induced metastasis2023
Method for treating neoadjuvant chemotherapy-induced metastasis2023
High resolution intravital imaging and uses thereof2023
Splicing-dependent transcriptional gene silencing or activation2023
Phosphocofilin: cofilin co-localization intensity as a predictor of metastatic r2021